Global tennis ball machine market was valued at $166.1 million in 2025 and is growing at a CAGR of 4.4% during the forecast period (2026-2035). Sports clubs play a significant role in the adoption and utilization of tennis ball machines, as these facilities focus on structured training, player development, and efficient use of coaching resources. Tennis ball machines help clubs deliver consistent practice sessions by enabling repetitive stroke training, footwork drills, and controlled ball placement for players of different skill levels. It supports both individual and group training, allowing coaches to manage larger numbers of athletes while maintaining training quality. Additionally, ball machines are used in clubs for junior development programs, performance enhancement, and off-peak practice, improving court utilization and overall training efficiency.

Rooftop solar panel market was valued at $41.2 billion in 2025 and is projected to reach $78.5 billion by 2035, growing at a CAGR of 6.8% during the forecast period (2026-2035). Rooftop solar is emerging as a central driver of change in the global solar panel market, supported by the shift toward distributed energy systems and on-site power generation. Rising electricity costs, grid reliability concerns, and space constraints in urban areas are accelerating adoption across both household and corporate sectors. Corporate users, in particular, are using rooftop installations to manage long-term energy costs and meet internal sustainability targets, while households are increasingly adopting rooftop systems to reduce dependence on centralized power supply. This momentum is directly influencing demand across panel types, with monocrystalline and polycrystalline silicon panels seeing strong uptake due to efficiency and space optimization needs in rooftop settings.

Global pharmacy automation market was valued at $6.5 billion in 2025 and is growing at a CAGR of 8.0% during the forecast period (2026-2035). The rising demand for automated pharmacy solutions is being driven by the growing emphasis on value-based care, medication adherence, and improved therapy outcomes. Healthcare organizations are increasingly seeking systems that integrate clinical analytics, AI, and decision support to optimize medication management, reduce errors, and lower overall healthcare costs. These trends are directly contributing to the growth of the global pharmacy automation market, as automated solutions enable efficient dispensing, monitoring, and management of complex therapies across large patient populations.

Global dysmenorrhea treatment market was valued at $2,115.3 million in 2025 and is projected to reach $4,579.4 million by 2035, growing at a CAGR of 8.1% during the forecast period (2026-2035). The heavy reliance on NSAIDs for managing menstrual pain, combined with their well-documented safety limitations, is a major driver shaping innovation and demand in the market. Dysmenorrhea is primarily mediated by excess prostaglandin production, making NSAIDs the first-line therapy across both primary and secondary dysmenorrhea. Its widespread use reflects the scale of unmet need, with an estimated 30 billion NSAID doses consumed annually in the US alone. However, long-term and recurrent NSAID use is associated with gastrointestinal injury, bleeding risk, and cardiovascular, renal, and hepatic complications. These risks are particularly relevant in dysmenorrhea, where patients often require repeated monthly dosing over several years. 

Jet injector market was valued at $190.3 million in 2025 and is expected to reach $346.7 million by 2035, expanding at a CAGR of 6.2% over the 2026–2035 forecast period. Rising industry investment and expanding clinical validation are emerging as a central driver for the jet injector market. Pharmaceutical companies and device developers are scaling needle-free platforms to improve vaccine delivery, enhance drug performance, and address injection hesitancy at the point of care. As these systems demonstrate faster workflows, simplified training, and compatibility with existing clinical practices, jet injectors are moving from niche use cases into mainstream immunization and therapeutic programs. This shift is strengthening adoption across vaccine delivery, insulin administration, and other applications, while reinforcing demand from pharmaceutical companies, hospitals, and clinical centres seeking safer, more efficient delivery alternatives.

Digital forensics market was valued at $12.6 billion in 2025 and is growing at a CAGR of 10.8% during the forecast period (2026-2035). Government and law enforcement agencies play an essential role in digital forensics by investigating, analyzing, and preserving electronic evidence to support legal proceedings and ensure public safety. It establishes standards, protocols, and frameworks for evidence collection, storage, and examinations to maintain integrity and admissibility in courts. These agencies collaborate with cybersecurity experts, private organizations, and international bodies to address cybercrime, data breaches, and digital fraud. Additionally, they provide training, resources, and technological tools to forensic teams, enabling the identification of criminal activity, attribution of cyber incidents, and enforcement of laws in a rapidly evolving digital landscape.

Immunosuppressive drug market was valued at $41.8 billion in 2025 and is expected to expand to $69.3 billion by 2035, registering a CAGR of 5.2% over the 2026–2035 forecast period. The increasing volume of organ transplant procedures globally and the rising prevalence of autoimmune diseases are major drivers for the immunosuppressive drug market. Solid organ transplant recipients require lifelong immunosuppressive therapy to prevent graft rejection, while individuals living with autoimmune conditions depend on these drugs to control immune-mediated inflammation and disease progression. As transplant activity expands and more people are diagnosed with autoimmune disorders, demand for calcineurin inhibitors, mTOR inhibitors, antiproliferative agents, steroids, and other immunosuppressive drugs continues to grow across hospitals and specialty treatment centers globally.

Global dental implants and prosthetics market was valued at $7.62 billion in 2025 and grew at a CAGR of 6.5% during the forecast period (2026-2035). The global dental implants and prosthetics market is primarily driven by the widespread and growing burden of oral diseases, which increases the need for restorative and rehabilitative dental treatments to replace missing or damaged teeth and restore oral function and aesthetics. The rising prevalence of dental caries, periodontal disease, tooth loss, and oral cancers continues to support long-term demand for dental implants, crowns, bridges, and other prosthetic solutions. For instance,

Glaucoma treatment market was valued at $7.2 billion in 2025 and is projected to reach $10.8 billion by 2035, growing at a CAGR of 4.2% during the forecast period (2026-2035). The global glaucoma treatment market is witnessing strong momentum due to the increasing prevalence of glaucoma and the critical need for early intervention to prevent irreversible vision loss. As awareness of the disease grows, patients are seeking timely access to effective therapies, including prescription eye drops, oral medications, laser therapies, and surgical procedures. This demand is further reinforced by healthcare providers emphasizing proactive disease management and patients’ preference for minimally invasive options, boosting adoption across hospitals, retail pharmacies, and online channels. Recent FDA approvals and product launches have accelerated access to advanced therapies, enhancing treatment options for both open-angle and closed-angle glaucoma patients.

E-Textile market is estimated at $880.1 million in 2025 and is expected to grow to $2,901.8 million by 2035, registering a CAGR of 12.7% over the 2026–2035 forecast period. E-textiles are gaining traction as the next frontier in wearable technology, driven by the expanding demand for integrated sensing, real-time physiological monitoring, and multifunctional textile solutions across healthcare, sports, and defense applications. Traditional wearables such as fitness bands and smartwatches are limited by rigid form factors and narrow monitoring scopes, whereas e-textiles embed sensors invisibly into garments, providing comfort and comprehensive data capture across the body. This shift is increasing adoption by healthcare providers, athletes, and defense organizations seeking continuous monitoring, early detection of health issues, and enhanced performance insights. The trend toward textiles that go beyond fashion and into connected, functional apparel is reshaping end-user expectations and prompting broader commercial deployment.